LLY compared with PRQR: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

PRQRProQR Therapeutics N.V.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

PRQRProQR Therapeutics N.V.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LLYELI Lilly & Co

1,407.25· pre 1,416.42· delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

PRQRProQR Therapeutics N.V.

1.36· pre 1.39· delayed

Pre-marketNov 3 '26delayed

Mkt cap$144.3MRevenue—Revenue—

Compare

Pre-marketNov 3 '26delayed

LLYELI Lilly & Co

PRQRProQR Therapeutics N.V.

1,407.25pre 1,416.42delayed

Price

1.36pre 1.39delayed

$1.3T

Mkt cap

$144.3M

Q3 FY26$24.4B

Revenue

—

FY25$65.2B

Revenue

—

LLY1,407.25vsPRQR1.36Pre-marketNov 3 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

LLY, solidPRQR, dashed

Supply-chain overlap

Revenue flow

PRQR: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only PRQR 1

LLYEli Lillycustomer

Role chip = supplier or customerSource: SEC EDGAR